PropertyValue
?:abstract
  • The poor success rate of treating patients with aggressive sepsis in SARS-CoV-2 infections has highlighted again the challenges of managing systemic inflammatory conditions. In this issue of JEM, Rodrigues et al. (https://doi.org/10.1084/jem.20201707) discuss the role of inflammasome activation in COVID-19 disease severity, opening new possibilities for therapeutic management of sepsis syndromes.
?:creator
?:doi
?:doi
  • 10.1084/jem.20202413
?:journal
  • J_Exp_Med
?:license
  • cc-by-nc-sa
?:pmc_json_files
  • document_parses/pmc_json/PMC7731946.xml.json
?:pmcid
?:pmid
?:pmid
  • 33289787.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • Medline; PMC
?:title
  • COVID-19 stokes inflammasomes
?:type
?:year
  • 2020-12-08

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/0b1w656f>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/0b1w656f>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all